ArticleBMC endocrine disorders2026
Prognostic biomarkers of future diabetes in South Asian women diagnosed with gestational diabetes: a prospective cohort study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundGestational diabetes (GDM) confers an increased risk of future type-2 diabetes (T2D). We aimed to identify determinants of the progression of GDM to T2D in South Asian women and develop a precision prognostics model for potential future clinical application.
methodsThis study included 247 South Asian women with GDM from the prospective South Asian Birth Cohort (START) study in Ontario, Canada. Metabolomics was performed on 2nd trimester fasting serum samples by multisegment injection-capillary electrophoresis-mass spectrometry. We determined incidence of postpartum T2D through validated diagnostic codes using health administrative data. We used multivariable logistic regression to identify predictors of incident T2D through backward elimination. We assessed diagnostic performance of models using area under the receiver operating characteristic curve (AUC ROC) and 5-fold cross-validation to assess model stability.
resultsOf 247 South Asian women diagnosed with GDM with a mean age of 30.9 years and median total follow-up of 9.7 years, 45 (18.2%) developed T2D within a median of 4.9 years. Pre-pregnancy body mass index, area-under-the-curve glucose, and level of education, were identified as the strongest determinants of T2D post-GDM (AUC ROC = 0.83 [95% Confidence Intervals (CI), 0.78-0.88]). Addition of metabolite biomarkers-specifically, the hypoxanthine-to-creatinine ratio-only modestly improved predictive performance (AUC ROC = 0.853 [CI, 0.80-0.91]). Folds mean (SD) of the AUC ROC from 5-fold cross-validation models was 0.81 (0.12).
conclusionsWe developed a parsimonious five-factor model combining clinical, anthropometric, and metabolic markers that accurately predicts T2D progression after GDM in South Asian women. This model can be potentially deployed at the time of GDM diagnosis to improve risk assessment and target intensive postpartum interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.